<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CAT</journal-id>
<journal-id journal-id-type="hwp">spcat</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Appl Thromb Hemost</journal-id>
<journal-title>Clinical and Applied Thrombosis/Hemostasis</journal-title>
<issn pub-type="ppub">1076-0296</issn>
<issn pub-type="epub">1938-2723</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1076029611435092</article-id>
<article-id pub-id-type="publisher-id">10.1177_1076029611435092</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Deep Vein Thrombosis, Tranexamic Acid, and a Negative <sc>d</sc>-Dimer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mihalache</surname>
<given-names>Raluca M.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1076029611435092">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ames</surname>
<given-names>Paul R. J.</given-names>
</name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-1076029611435092">1</xref>
<xref ref-type="corresp" rid="corresp1-1076029611435092"/>
</contrib>
<aff id="aff1-1076029611435092">
<label>1</label>Department of Haematology, Royal Glamorgan Hospital, Llantrisant, UK</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1076029611435092">Paul R. J. Ames, Department of Haematology, Royal Glamorgan Hospital, Llantrisant, CF728XR, UK. Email: <email>paxmes@aol.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>6</issue>
<fpage>666</fpage>
<lpage>667</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>A 38-year-old female presented to her general practitioner (GP) for a painful left calf and minimal pitting edema. Ten years earlier, she suffered a deep vein thrombosis (DVT) in the right leg and had been on amisulpride (200 mg twice daily) for the previous 16 months that had lead to a weight gain of 11 kg. A thrombophilia screening at the time of the previous DVT revealed elevated homocysteine (normalized on ongoing oral folate) but normal plasma levels of natural anticoagulants, homozygous normal factor V Leiden, and prothrombin 20 210 genes. Antiphospholipid antibodies detected by kaolin clotting time, activated partial thromboplastin time, dilute Russell venom viper time, and anticardiolipin and β-2-glycoprotein-I of immunoglobulin (Ig) G and IgM isotype were all negative.</p>
<p>Her Well’s score was 2 (tenderness along deep venous system and minimal pitting edema), but a negative <sc>d</sc>-dimer ([DD]; 240 ng/mL; positive &gt;320 ng/mL; NycoCard, Axis-Shield, Dundee, Scotland) ruled out the need for a Doppler ultrasound of the leg. Plasma homocysteine and antiphospholipid antibodies were also normal. Due to persistent pain in the left leg, 2 days later, the patient attended a private hospital where the DD was again negative (280 ng/mL; positive &gt;300 ng/mL; Instrumentation Laboratory, Milan, Italy), but a Doppler ultrasound showed thrombus in left calf and popliteal vein: thromboprophylaxis with low-molecular-weight heparin and then warfarin was started.</p>
<p>Unbeknown to the GP, a gynecologist had prescribed tranexamic acid ([TA] 500 mg 4 times daily) for menorrhagia to cover the lady’s menstrual period. The DVT developed at the 6th day of TA treatment, but the patient did not inform the GP about it preventing the correct interpretation of the DD results that was falsely negative twice likely because of the antifibrinolytic activity of TA. False-negative DD may occur in small DVT,<sup><xref ref-type="bibr" rid="bibr1-1076029611435092">1</xref></sup> in pregnancy-related DVT,<sup><xref ref-type="bibr" rid="bibr2-1076029611435092">2</xref></sup> in some patients with trauma,<sup><xref ref-type="bibr" rid="bibr3-1076029611435092">3</xref></sup> and in disseminated intravascular coagulation.<sup><xref ref-type="bibr" rid="bibr4-1076029611435092">4</xref></sup>
</p>
<p>Nonetheless, this lady had several risk factors for thrombosis: a previous DVT, being overweight, the use of an antipsychotic drug, and of an antifibrinolytic agent albeit for a short time. Observational surveys suggest an increased risk of DVT in psychiatric patients on antipsychotic medication,<sup><xref ref-type="bibr" rid="bibr5-1076029611435092">5</xref></sup> recently confirmed in a case–control study,<sup><xref ref-type="bibr" rid="bibr6-1076029611435092">6</xref></sup> although controversy exists.<sup><xref ref-type="bibr" rid="bibr7-1076029611435092">7</xref></sup> Several case reports described the occurrence of occlusions in different vascular districts in users of TA: arterial<sup><xref ref-type="bibr" rid="bibr8-1076029611435092">8</xref>
<xref ref-type="bibr" rid="bibr9-1076029611435092"/>–<xref ref-type="bibr" rid="bibr10-1076029611435092">10</xref></sup> and venous cerebral vessels,<sup><xref ref-type="bibr" rid="bibr11-1076029611435092">11</xref></sup> venous limb vessels,<sup><xref ref-type="bibr" rid="bibr12-1076029611435092">12</xref>,<xref ref-type="bibr" rid="bibr13-1076029611435092">13</xref></sup> and pulmonary embolism.<sup><xref ref-type="bibr" rid="bibr14-1076029611435092">14</xref>,<xref ref-type="bibr" rid="bibr15-1076029611435092">15</xref></sup> Fatal cerebral and renal microvascular occlusions have been described in patients receiving all-trans retinoic acid together with TA for acute promyelocytic leukemia.<sup><xref ref-type="bibr" rid="bibr16-1076029611435092">16</xref>,<xref ref-type="bibr" rid="bibr17-1076029611435092">17</xref></sup> Conversely 2 studies found neither an increased risk of thrombosis in women taking TA for menstrual bleeding<sup><xref ref-type="bibr" rid="bibr18-1076029611435092">18</xref>,<xref ref-type="bibr" rid="bibr19-1076029611435092">19</xref></sup> nor for pregnancy-related bleeding.<sup><xref ref-type="bibr" rid="bibr20-1076029611435092">20</xref></sup> A link between TA and thrombosis was also refuted in the liver transplantation setting.<sup><xref ref-type="bibr" rid="bibr21-1076029611435092">21</xref></sup>
</p>
<p>Our case adds to the rarity of thrombosis in patients taking antipsychotic drugs and TA acid. Moreover, it highlights the possible association between antifibrinolytic treatment with TA and falsely negative results of DD determinations. Although circumstantial in nature, such observations should prompt discerning clinicians to do their utmost to extract complete anamnestic information from their patients while not out ruling the diagnosis of DVT in patients with risk factors and elusive clinical signs under TA treatment, in the presence of negative DD determinations.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1076029611435092">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turkstra</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van Beek</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Buller</surname>
<given-names>HR</given-names>
</name>
</person-group>. <article-title>Observer and biological variation of a rapid whole blood D-dimer test</article-title>. <source>Thromb Haemost</source>. <year>1998</year>;<volume>79</volume>(<issue>1</issue>):<fpage>91</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr2-1076029611435092">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>To</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Nelson-Piercy</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy</article-title>. <source>J Obstet Gynaecol</source>. <year>2008</year>;<volume>28</volume>(<issue>2</issue>):<fpage>222</fpage>–<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr3-1076029611435092">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahl</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Ahrns</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Zajkowski</surname>
<given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Normal D-dimer levels do not exclude thrombotic complications in trauma patients</article-title>. <source>Surgery</source>. <year>2003</year>;<volume>134</volume>(<issue>4</issue>):<fpage>529</fpage>–<lpage>532</lpage>.</citation>
</ref>
<ref id="bibr4-1076029611435092">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Constantinescu</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Berendes</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>MD</given-names>
</name>
</person-group>. <article-title>Disseminated intravascular coagulation and a negative D-dimer test</article-title>. <source>Neth J Med</source>. <year>2007</year>;<volume>65</volume>(<issue>10</issue>):<fpage>398</fpage>–<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr5-1076029611435092">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hägg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jönsson</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Spigset</surname>
<given-names>O</given-names>
</name>
</person-group>. <article-title>Risk of venous thromboembolism due to antipsychotic drug therapy</article-title>. <source>Expert Opin Drug Saf</source>. <year>2009</year>;<volume>8</volume>(<issue>5</issue>):<fpage>537</fpage>–<lpage>547</lpage>.</citation>
</ref>
<ref id="bibr6-1076029611435092">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coupland</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hippisley-Cox</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Antipsychotic drugs and risk of venous thromboembolism: nested case-control study</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>341</volume>:<fpage>4245</fpage>.</citation>
</ref>
<ref id="bibr7-1076029611435092">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleijer</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Heerdink</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Egberts</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>van Marum</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Antipsychotic drug use and the risk of venous thromboembolism in elderly patients</article-title>. <source>J Clin Psychopharmacol</source>. <year>2010</year>;<volume>30</volume>(<issue>5</issue>):<fpage>526</fpage>–<lpage>530</lpage>.</citation>
</ref>
<ref id="bibr8-1076029611435092">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rydin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>PO</given-names>
</name>
</person-group>. <article-title>Tranexamic acid and intracranial thrombosis</article-title>. <source>Lancet</source>. <year>1976</year>;<volume>2</volume>(<issue>7975</issue>):<fpage>49</fpage>.</citation>
</ref>
<ref id="bibr9-1076029611435092">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agnelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gresele</surname>
<given-names>P</given-names>
</name>
<name>
<surname>De Cunto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gallai</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nenci</surname>
<given-names>GG</given-names>
</name>
</person-group>. <article-title>Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report</article-title>. <source>Br J Obstet Gynaecol</source>. <year>1982</year>;<volume>89</volume>(<issue>8</issue>):<fpage>681</fpage>–<lpage>682</lpage>.</citation>
</ref>
<ref id="bibr10-1076029611435092">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanghetti</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Capra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Spontaneous thrombosis of ruptured intracranial aneurysm during treatment with tranexanic acid. Case report</article-title>. <source>J Neurosurg Sci</source>. <year>1985</year>;<volume>29</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr11-1076029611435092">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humbert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gutknecht</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mallet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dupond</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Leconte</surname>
<given-names>des</given-names>
</name>
<name>
<surname>Floris</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Tranexamic acid and thrombosis of the superior longitudinal sinus</article-title>. <source>Therapie</source>. <year>1987</year>;<volume>42</volume>(<issue>1</issue>):<fpage>65</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr12-1076029611435092">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura</article-title>. <source>JAMA</source>. <year>1988</year>;<volume>259</volume>(<issue>24</issue>):<fpage>3561</fpage>–<lpage>3562</lpage>.</citation>
</ref>
<ref id="bibr13-1076029611435092">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escher</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Extensive venous thrombosis following administration of high-dose glucocorticosteroids and tranexamic acid in relapsed Evans syndrome</article-title>. <source>Blood Coagul Fibrinolysis</source>. <year>2008</year>;<volume>19</volume>(<issue>7</issue>):<fpage> 741</fpage>–<lpage>742</lpage>.</citation>
</ref>
<ref id="bibr14-1076029611435092">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woo</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Tse</surname>
<given-names>LKK</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>JLF</given-names>
</name>
<etal/>
</person-group>. <article-title>Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy</article-title>. <source>Br J Clin Pract</source>. <year>1989</year>;<volume>43</volume>(<issue>12</issue>):<fpage>465</fpage>–<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr15-1076029611435092">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taparia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cordingley</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Leahy</surname>
<given-names>MF</given-names>
</name>
</person-group>. <article-title>Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia</article-title>. <source>Eur J Haematol</source>. <year>2002</year>;<volume>68</volume>(<issue>5</issue>):<fpage>307</fpage>–<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr16-1076029611435092">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tatewaki</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with anti-fibrinolytic therapy for prophylaxis of hemorrhage</article-title>. <source>Leukemia</source>. <year>1994</year>;<volume>8</volume>(<issue>7</issue>):<fpage>1113</fpage>–<lpage>1115</lpage>.</citation>
</ref>
<ref id="bibr17-1076029611435092">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Olujohungbe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia</article-title>. <source>Br J Haematol</source>. <year>2000</year>;<volume>110</volume>(<issue>4</issue>):<fpage>1010</fpage>–<lpage>1012</lpage>.</citation>
</ref>
<ref id="bibr18-1076029611435092">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berntorp</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Follrud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lethagen</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>No increased risk of venous thrombosis in women taking tranexamic acid</article-title>. <source>Thromb Haemost</source>. <year>2001</year>;<volume>86</volume>(<issue>2</issue>):<fpage>714</fpage>–<lpage>715</lpage>.</citation>
</ref>
<ref id="bibr19-1076029611435092">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundström</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Seaman</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kieler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alfredsson</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the general practice research database</article-title>. <source>BJOG</source>. <year>2009</year>;<volume>116</volume>(<issue>1</issue>):<fpage>91</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr20-1076029611435092">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindoff</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rybo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Astedt</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications</article-title>. <source>Thromb Haemost</source>. <year>1993</year>;<volume>70</volume>(<issue>2</issue>):<fpage>238</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr21-1076029611435092">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalmau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sabaté</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rafecas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Figueras</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Jaurrieta Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation</article-title>. <source>Anesth Analg</source>. <year>2001</year>;<volume>93</volume>(<issue>2</issue>):<fpage>516</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>